These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32848722)

  • 1. Serious Adverse Drug Reactions and Safety Signals in Children: A Nationwide Database Study.
    Vieira JML; de Matos GC; da Silva FAB; Bracken LE; Peak M; Lima EDC
    Front Pharmacol; 2020; 11():964. PubMed ID: 32848722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System.
    Barcelos FC; de Matos GC; da Silva MJS; da Silva FAB; Lima EDC
    Front Pharmacol; 2019; 10():498. PubMed ID: 31139083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study.
    Lima EDC; Matos GC; Vieira JML; Gonçalves ICDCR; Cabral LM; Turner MA
    J Pediatr (Rio J); 2019; 95(6):682-688. PubMed ID: 30030984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the Under-Reporting of Suspected Serious Adverse Drug Reactions in Japan Using An Interrupted Time Series Analysis.
    Ito S; Narukawa M
    Ther Innov Regul Sci; 2022 Mar; 56(2):358-365. PubMed ID: 35124790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France.
    Salvo F; Leborgne F; Thiessard F; Moore N; Bégaud B; Pariente A
    Drug Saf; 2013 Jul; 36(7):565-72. PubMed ID: 23673817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow).
    Barbosa LHLA; Silva ARO; Carvalho-Assef APD; Lima EC; da Silva FAB
    Front Pharmacol; 2022; 13():948339. PubMed ID: 36204235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World.
    Campillo JT; Boussinesq M; Bertout S; Faillie JL; Chesnais CB
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009354. PubMed ID: 33878105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].
    Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database.
    Hauben M; Hung EY; Hanretta KC; Bangalore S; Snow V
    Drug Saf; 2015 Nov; 38(11):1127-39. PubMed ID: 26242615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review.
    Dias P; Penedones A; Alves C; Ribeiro CF; Marques FB
    Curr Drug Saf; 2015; 10(3):234-50. PubMed ID: 26219291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of consumer reporting on signal detection: using disproportionality analysis.
    Hammond IW; Rich DS; Gibbs TG
    Expert Opin Drug Saf; 2007 Nov; 6(6):705-12. PubMed ID: 17967159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
    Iqbal S; Shi J; Seib K; Lewis P; Moro PL; Woo EJ; Shimabukuro T; Orenstein WA
    Lancet Infect Dis; 2015 Oct; 15(10):1175-1182. PubMed ID: 26289956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database.
    Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ
    Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration's Adverse Event Reporting System, 2010-2017.
    Dores GM; Bryant-Genevier M; Perez-Vilar S
    JAMA Netw Open; 2019 Aug; 2(8):e199249. PubMed ID: 31411714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.